Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

NCT01103037 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated by sponsor

Conditions

Asthma

Interventions

DRUG: QAV680
DRUG: QAV680 Placebo

Sponsor

Novartis Pharmaceuticals